VTAK Catheter Precision, Inc.

NEUTRAL Impact: 4/10 8-K
Horizon weeks Filed Jun 8, 2026 Processed 5d 7h ago SEC 0001437749-26-019779
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)

Price Chart

Loading chart...

Executive Summary

Catheter Precision (VTAK) entered into a Securities Purchase Agreement to purchase 2,941,176 shares of Volato Group (SOAR) common stock at $0.34/share for $1,000,000 in a private placement. As consideration for VTAK's participation, Volato agreed to deliver 451,901 freely tradeable shares of flyExclusive, Inc. common stock to VTAK, valued at approximately $1,100,000 as of June 5, 2026. The transaction is structured as a strategic investment by VTAK in SOAR, with VTAK receiving additional compensation in the form of third-party equity securities.

Key Financial Metrics

Deal Value
$1.0M

Actionable Insight

Monitor the closing conditions and subsequent registration statement filing by Volato. The freely tradeable flyExclusive shares received by VTAK provide a liquid asset that can be sold immediately, while the SOAR shares are restricted until registration. The transaction does not change VTAK's operational outlook but represents a $1,000,000 cash deployment into a strategic investment.

Key Facts

  • VTAK agreed to purchase 2,941,176 shares of SOAR common stock at $0.34/share for an aggregate purchase price of $1,000,000.
  • As consideration for VTAK's participation, Volato agreed to deliver 451,901 freely tradeable shares of flyExclusive, Inc. common stock to VTAK, valued at approximately $1,100,000 as of June 5, 2026.
  • The closing is subject to customary conditions including accuracy of representations, performance of covenants, and absence of a Material Adverse Effect with respect to Volato.
  • VTAK received registration rights requiring Volato to file a resale registration statement on Form S-3 within 10 calendar days and use best efforts to have it declared effective.
  • The total aggregate offering under the Purchase Agreement is approximately $2,210,000 across all purchasers, with VTAK's subscription amount being $1,000,000.

Financial Impact

VTAK deployed $1,000,000 cash to acquire SOAR shares and received approximately $1,100,000 in freely tradeable flyExclusive shares as a participation incentive. Net cash outflow of $1,000,000 with a non-cash compensation asset of ~$1,100,000.

cashinvestmentsequity securities holdings

Risk Factors

  • The closing is subject to conditions including no Material Adverse Effect at Volato — if Volato's business deteriorates, the deal may not close.
  • The $1,000,000 cash outlay reduces VTAK's cash reserves for its own operations.
  • The value of the SOAR shares and flyExclusive shares received is subject to market volatility — there is no guarantee VTAK will realize the current market values through future sales.
  • Registration rights are subject to carve-outs for Excluded Registration Events which could delay resale of SOAR shares.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-019779
Exhibit: ex_973563.htm0001437749-26-019779
Document: vtak20260607_8k.htm0001437749-26-019779
Document: 0001437749-26-019779-index-headers.html0001437749-26-019779
Document: 0001437749-26-019779-index.html0001437749-26-019779
Document: 0001437749-26-019779.txt0001437749-26-019779
11 reports for VTAK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VTAK — sortable, filterable
Type Now
Jun 8, 2026
5d ago
Press Release
NEUTRAL ★ 3/10
$0.9875 awaiting T+20awaiting T+20$1.05 (+6.33%)
Jun 8, 2026
5d ago
8-K
NEUTRAL ★ 4/10
$0.9875 awaiting T+20awaiting T+20$1.05 (+6.33%)
May 4, 2026
5w ago
Press Release
NEUTRAL ★ 2/10
$0.9400 $0.9200▼ −2.13%▼ −7.77%$1.05 (+11.70%)
Apr 21, 2026
7w ago
Press Release
BULLISH ★ 6/10
$0.9500 $0.8300▼ −12.63%▼ −17.55%$1.05 (+10.53%)
Apr 20, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$0.9800 $0.8300▼ −15.31%▼ −19.51%$1.05 (+7.14%)
Apr 8, 2026
9w ago
Press Release
NEUTRAL ★ 3/10
$0.8600 $0.9300▲ +8.14%▼ −0.41%$1.05 (+22.09%)
Apr 6, 2026
9w ago
Press Release
NEUTRAL ★ 4/10
$0.9500 $0.9400▼ −1.05%▼ −10.04%$1.05 (+10.53%)
Mar 31, 2026
10w ago
8-K
MIXED ★ 6/10
$0.9400 $0.9400· 0.00%▼ −9.72%$1.05 (+11.70%)
Mar 31, 2026
10w ago
Press Release
MIXED ★ 6/10
$1.01 $0.9201▼ −8.90%▼ −18.32%$1.05 (+3.96%)
Mar 23, 2026
11w ago
DEFA14A
BEARISH ★ 7/10
$1.20 $0.9600▲ +20.00%▲ +28.90%$1.05 (+12.50%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (43h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access